PaulRobertKaywinMD

Hematologic Oncology, Thoracic Cancer

Physician

Overview of Dr. Kaywin

Dr. Paul Kaywin is an oncologist in Miami, FL and is affiliated with multiple hospitals in the area, including Baptist Hospital of Miami, South Miami Hospital, Doctors Hospital, Homestead Hospital, West Kendall Baptist Hospital, and Mariners Hospital. He received his medical degree from Boston University School of Medicine and has been in practice 44 years. He is one of 58 doctors at Baptist Hospital of Miami and one of 19 doctors at Homestead Hospital who specialize in Oncology. He has 8 publications and over 350 citings.

Office
Baptist Health Miami Cancer Institute
8900 N Kendall Dr
Miami, FL 33176
Book by Phone+1(866) 756-1177
Is this information wrong?

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1976 - 1979
St Elizabeth's Medical CenterResidency, Internal Medicine, 1973 - 1976
Boston University School of MedicineClass of 1973

Certifications & Licensure

FL State Medical License 1979 - 2025
PA State Medical License 1976 - 1981
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top Doctors:South Florida Castle Connolly, 2012
Top Doctors: Florida Castle Connolly, 2000
Top MD Consumers Checkbook
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
Active, not recruiting
Phase 3
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
No longer available
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Start of enrollment: 2014 Mar 27
Completed
Phase 3
A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

6 citations
Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data.
Haley Appel, Maria Carolina Avendano, Federico Albrecht, Paul Kaywin, Suyen Ramos, Melanie E Suarez-Murias, Minesh P Mehta, Rupesh Kotecha, Tugce Kutuk> ;Cancers. 2022 Apr 16
8 citations
Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy.
Rupesh Kotecha, Raees Tonse, Muni Rubens, Haley Appel, Federico Albrecht, Paul Kaywin, Evan W. Alley, M.C. Tom, Minesh P. Mehta> ;Cancers. 2021 May 2
15 citations
Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in ...
Edith A. Perez, Barry C. Lembersky, Paul Kaywin, Leonard Kalman, Karen Yocom, Carl Friedman> ;The Cancer Journal from Scientific American. 1998 Jan 1
193 citations
Heparin-Associated Thrombocytopenia
Douglas B. Cines, Paul Kaywin, Mahin Bina, Ann Tomaski, Alan D. Schreiber> ;The New England Journal of Medicine. 1980 Oct 2
161 citations
Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors.
Paul Kaywin, Margaret McDonough, Paul A. Insel, Sanford J. Shattil> ;The New England Journal of Medicine. 1978 Sep 7
Letter: Non-Thanksgiving turkey.
Kaywin, P. R.> ;N Engl J Med. 1973 Dec 06
High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin''s lymphoma: results of outpatient treatment in community cancer centers.
Weaver, C. H., Schwartzberg, L., Zhen, B., Mangum, M., Leff, R., Tauer, K., Rosenberg, A., Pendergrass, K., Kaywin, P., Hainsworth, J., Greco, F. A., West, W. H., Buck...> ;Bone Marrow Transplant. 1997 Nov
Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content.
Weaver, C. H., Potz, J., Redmond, J., Tauer, K., Schwartzberg, L. S., Kaywin, P., Drapkin, R., Grant, B., Unger, P., Allen, C., Longin, K., Zhen, B., Hazelton, B., Buc...> ;Bone Marrow Transplant. 1997 Jun
Join now to see all

Press Mentions

This Keys Diver Has Beat Back Stage Four Lung Cancer — Thanks to Targeted TherapyMay 21st, 2019
Targeted Therapy Helping Lung Cancer Patients Live LongerMay 21st, 2019